Greenlane (GNLN) Stock Price, News & Analysis

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GNLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNLN, but not buy additional shares or sell existing shares.
View GNLN analyst ratings or view top-rated stocks.

Greenlane's stock was trading at $0.5180 at the beginning of the year. Since then, GNLN stock has increased by 21.6% and is now trading at $0.63.
View the best growth stocks for 2024 here.

Greenlane saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 10,700 shares, a decline of 79.3% from the March 15th total of 51,800 shares. Based on an average daily volume of 214,600 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.3% of the company's stock are sold short.
View Greenlane's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our GNLN earnings forecast.

Greenlane Holdings, Inc. (NASDAQ:GNLN) issued its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analysts' expectations of $40.31 million. Greenlane had a negative trailing twelve-month return on equity of 80.94% and a negative net margin of 57.00%. During the same period in the prior year, the business earned ($92.00) earnings per share.

AXS Cannabis ETF holds 63,837 shares of GNLN stock, representing 0.42% of its portfolio.

Greenlane shares reverse split on the morning of Tuesday, June 6th 2023. The 1-10 reverse split was announced on Tuesday, June 6th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include KushCo (KSHB), Organigram (OGI), Enerplus (ERF), Matinas BioPharma (MTNB), Supreme Cannabis (SPRWF), ADMA Biologics (ADMA), EnLink Midstream (ENLC), Gran Tierra Energy (GTE), MariMed (MRMD) and Novan (NOVN).

Greenlane (GNLN) raised $80 million in an initial public offering on Thursday, April 18th 2019. The company issued 5,300,000 shares at $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Shares of GNLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.